市场调查报告书
商品编码
1450944
2024-2032 年按刺激类型、产品、应用(帕金森氏症、癫痫、肌张力失调、强迫症等)、最终用户和地区分類的深部脑刺激市场报告Deep Brain Stimulation Market Report by Stimulation Type, Product, Application (Parkinson's Disease, Epilepsy, Dystonia, Obsessive Compulsive Disorder, and Others), End-User, and Region 2024-2032 |
2023年,全球深部脑部刺激市场规模达到13亿美元。展望未来, IMARC Group预计到2032年市场规模将达到26亿美元,2024-2032年复合年增长率(CAGR)为8.3%。大众各种运动和神经系统疾病的发生率不断上升,微创(MI)手术方法的接受度不断提高,以及全球医院、疗养院和诊所的建设,是推动市场的一些关键因素。
深部脑部刺激 (DBS) 是指有助于治疗各种神经和运动相关疾病的外科手术,例如帕金森氏症、癫痫、肌张力失调和强迫症 (OCD)。它涉及在大脑的某些区域植入电极以产生电脉衝来调节大脑中的异常脉衝。它依赖于一种类似起搏器的设备,称为可编程发生器,放置在患者上胸部的皮肤下,并用一根电线将该设备连接到电极。它可以阻止神经功能障碍的形成,引起衝动,并帮助大脑有效运作。它可以帮助患者应对震颤、僵硬和运动障碍,而无需完全依赖高剂量的药物。它用于治疗抽动秽语症候群、亨廷顿舞蹈症、舞蹈病、丛集性头痛和慢性疼痛。当药物不再有效地维持患者良好的生活品质时,也会使用它。此外,由于 DBS 以受控方式直接改变大脑活动,因此受到世界各地神经外科医生、神经科医生、神经心理学家和精神病学家的推荐。
目前,由于群众中各种运动和神经系统疾病的发生率上升,对 DBS 的需求不断增加,这是对市场产生正面影响的主要因素之一。除此之外,越来越多的人接受微创 (MI) 手术方法来减少术后疤痕、最大限度地降低医疗费用并缩短住院时间,这提供了良好的市场前景。此外,医院、疗养院和诊所的建设也在增加,以便为全球患者提供优质的医疗保健服务。随着在改善各种神经和心理疾病的治疗和诊断方面取得的不断进步,正在推动市场的成长。除此之外,人们越来越意识到 DBS 的好处和神经系统併发症的早期发现,以及全球老年人口的不断增加,正在支持市场的成长。此外,工作人员中各种生活方式障碍和高血压引起的忧郁症的发生率不断上升,也正在加强市场的成长。此外,主要市场参与者正在将人工智慧 (AI) 和物联网 (IoT) 融入 DBS 系统中,以创建机器人辅助植入和多目标刺激。
The global deep brain stimulation market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of the key factors driving the market.
Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson's disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington's disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.
At present, the increasing demand for DBS due to the rising occurrence of various motor and neurological disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing acceptance of minimally invasive (MI) surgical methods to reduce post-operative scarring, minimize the cost of medical bills, and decrease the duration of hospital stays is offering a favorable market outlook. Additionally, there is an increase in the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe. This, along with the rising number of advancements made in improving the treatment and diagnosis of various neurological and psychological disorders, is propelling the growth of the market. Apart from this, the increasing awareness about the benefits of DBS and early detection of neurological complications, along with the rising geriatric population worldwide, is supporting the growth of the market. In addition, the rising occurrence of various lifestyle disorders and hypertension-induced depression among working individuals is strengthening the market growth. Moreover, key market players are incorporating artificial intelligence (AI) and the internet of things (IoT) in DBS systems to create robot-assisted implantations and multitarget stimulations.
IMARC Group provides an analysis of the key trends in each segment of the global deep brain stimulation market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on stimulation type, product, application, and end-user.
Subthalamic DBS
Globus Pallidus DBS
Thalamic DBS
Pedunculopontine Nucleus DBS
The report has provided a detailed breakup and analysis of the deep brain stimulation market based on the stimulation type. This includes subthalamic DBS, globus pallidus DBS, thalamic DBS, and pedunculopontine nucleus DBS.
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
A detailed breakup and analysis of the deep brain stimulation market based on the product has also been provided in the report. This includes single channel deep brain stimulator and dual channel deep brain stimulator. According to the report, dual channel deep brain stimulator accounted for the largest market share.
Parkinson's Disease (PD)
Epilepsy
Dystonia
Obsessive Compulsive Disorder (OCD)
Others
A detailed breakup and analysis of the deep brain stimulation market based on the application has also been provided in the report. This includes Parkinson's disease (PD), epilepsy, dystonia, obsessive compulsive disorder (OCD), and others. According to the report, Parkinson's disease (PD) accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Neurological Centers
Others
A detailed breakup and analysis of the deep brain stimulation market based on the end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, neurological centers, and others. According to the report, hospitals accounted for the largest market share.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for deep brain stimulation. Some of the factors driving the North America deep brain stimulation market included the growing investment in the medical sector, rising construction of healthcare facilities, increasing occurrence of various neurological conditions among the masses, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global deep brain stimulation market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, Neuro Sigma, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.